Features of pharmacotherapy for gastroesophageal reflux disease in pregnant women

Journal Title: Гастроентерологія - Year 2019, Vol 53, Issue 3

Abstract

The article deals with the problem of gastroesophageal reflux disease in pregnant women. The peculiarities of the mechanism of developing this disease in pregnant women are highlighted. A number of scientific studies of different authors on the safety of therapeutic measures in this category of patients have been analyzed. The author focuses on the presence of unresolved issues in pharmacotherapy for gastroesophageal reflux disease in pregnant women.

Authors and Affiliations

Yu. S. Breslavets

Keywords

Related Articles

Features of Treatment of Patients Infected with Hepatitis C Virus Genotypes 1 And 4 by Direct-Acting Antiviral Drugs

Hepatitis C is an urgent problem today because of the low efficiency and a significant number of side effects of conventional therapy. The problem of the treatment of hepatitis C virus (HCV) genotypes 1 and 4 is particul...

Functional Features of the Pancreas during Chronic Pancreatitis

Aim of study: to identify functional status of pancreas in patients with chronic pancreatitis depending on the stage of fibrotic transformation and activity of parenchymal inflammation. Materials and methods. The preoper...

Evaluating the Effectiveness of Essential Phospholipids in Patients with Chronic Viral Hepatitis C

The study evaluated the effectiveness of essential phospholipids in patients with chronic viral hepatitis C. A positive dynamics of clinical symptoms, liver function tests, lipid metabolism and elastography data has been...

Peculiarities of Abdominal Pain Syndrome in Patients with Functional and Inflammatory Bowel Diseases and Methods of Its Correction

Objective of this study was to evaluate peculiarities of abdominal pain syndrome in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) and to assess efficacy of Enterospasmil in complex the...

Clinical and hemodynamic aspects of hepatic and extrahepatic portal hypertension

Background. Significant variability of the quantitative indices of portal blood flow in chronic hepatitis, cirrhosis, chronic heart failure, Budd-Chiari disease confirms the need for further search for clinical and hemod...

Download PDF file
  • EP ID EP668165
  • DOI 10.22141/2308-2097.53.3.2019.181472
  • Views 91
  • Downloads 0

How To Cite

Yu. S. Breslavets (2019). Features of pharmacotherapy for gastroesophageal reflux disease in pregnant women. Гастроентерологія, 53(3), 196-202. https://europub.co.uk./articles/-A-668165